Moderate Evidence

Promising research with growing clinical support from multiple studies

Multiple Sclerosis — Western vs Eastern Complementary Care

Multiple sclerosis (MS) is a chronic, immune‑mediated condition in which inflammation damages myelin and axons in the central nervous system, producing symptoms such as fatigue, numbness, weakness, visual changes, spasticity, pain, cognitive issues, and mobility limitations. Western biomedicine has transformed MS care with disease‑modifying therapies (DMTs) that reduce relapse risk and MRI activity and, for some people, slow disability progression. Yet DMTs do not cure MS, can have significant side effects, and are less effective for progressive forms. These realities, alongside symptom burdens (fatigue, pain, mood changes, sleep disturbance) and a desire for self‑care, motivate many to explore complementary and alternative approaches. Comparing Western and Eastern perspectives helps patients and clinicians navigate options in a realistic, evidence‑aware way. In Western practice, diagnosis relies on the 2017 McDonald criteria integrating clinical history, MRI evidence of lesions disseminated in space and time, and supportive tests such as cerebrospinal fluid oligoclonal bands and evoked potentials. Acute relapses are often treated with high‑dose corticosteroids; plasma exchange may be used for steroid‑refractory attacks. Long‑term DMTs (e.g., interferon beta, glatiramer acetate, fumarates, teriflunomide, sphingosine‑1‑phosphate modulators, natalizumab, ocrelizumab, ofatumumab, alemtuzumab, cladribine) have strong evidence from randomized trials and guidelines. Symptom management, rehabilitation (physical/occupational therapy), exercise, smoking cessation, and mental health care are core elements. Limitations include incomplete disease control, monitoring burdens, infection and other risks (e.g., PML with natalizumab), high costs, and limited options for primary progressive disease. Eastern medical systems conceptualize MS differently. In Traditional Chinese Medicine (TCM), patterns such as “wind,” “dampness,” “phlegm,” and deficiencies of liver–kidney yin or qi/b血

neurological Updated March 17, 2026

This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any supplement or medication regimen.

Western Medicine

Diagnosis

MS is identified using the 2017 McDonald criteria: clinical attacks affecting different CNS sites, MRI evidence of dissemination in space and time, cerebrospinal fluid oligoclonal bands as supportive evidence, and evoked potentials when needed. Differential diagnosis excludes mimics (e.g., neuromyelitis optica spectrum disorder, vascular, infectious, metabolic). Baseline and follow‑up MRIs monitor disease activity and treatment response.

Treatments

  • Acute relapse management with high‑dose corticosteroids; plasma exchange for steroid‑refractory relapses
  • Disease‑modifying therapies (platform and high‑efficacy agents) to reduce relapses/MRI activity and slow progression
  • Hematopoietic stem cell transplantation (HSCT) for highly active, treatment‑refractory relapsing MS in specialized centers
  • Vaccination, infection‑risk mitigation, and safety monitoring tailored to DMTs
  • Multidisciplinary rehabilitation: physical/occupational therapy, speech therapy, mobility aids
  • Lifestyle interventions: regular exercise/aerobic and resistance training, smoking cessation, sleep optimization, heat management
  • Symptom‑targeted care: spasticity management, pain/neuropathic pain care, bladder/bowel strategies, fatigue and mood support

Medications

  • methylprednisolone
  • prednisone
  • interferon beta‑1a
  • interferon beta‑1b
  • peginterferon beta‑1a
  • glatiramer acetate
  • dimethyl fumarate
  • diroximel fumarate
  • teriflunomide
  • fingolimod
  • ozanimod
  • siponimod
  • ponesimod
  • natalizumab
  • ocrelizumab
  • ofatumumab
  • alemtuzumab
  • cladribine
  • mitoxantrone
  • baclofen
  • tizanidine
  • dantrolene
  • onabotulinumtoxinA
  • gabapentin
  • pregabalin
  • duloxetine
  • amitriptyline
  • carbamazepine
  • dalfampridine
  • amantadine
  • modafinil
  • armodafinil
  • oxybutynin
  • solifenacin
  • mirabegron
  • desmopressin
  • sertraline
  • escitalopram
  • venlafaxine

Limitations

DMTs do not cure MS and are variably effective, especially in progressive phenotypes. Some require infusions/injections and intensive monitoring; adverse events include infections, infusion reactions, lymphopenia, hepatotoxicity, and rare risks such as PML (natalizumab) or autoimmune events (alemtuzumab). Access and costs can be substantial. Symptom and quality‑of‑life burdens (fatigue, pain, cognitive impairment) often persist despite optimal biomedical care.

Evidence: Strong Evidence

Sources

  • 2017 McDonald criteria for MS diagnosis (Thompson et al., Lancet Neurol.)
  • ECTRIMS/EAN 2023 guideline on pharmacological treatment of MS
  • American Academy of Neurology (AAN) practice guidelines on DMTs for MS (2018–2020 updates)
  • Cochrane reviews and network meta‑analyses finding DMTs reduce relapse rates and MRI activity in RRMS
  • National MS Society clinical resources on relapse management and rehabilitation

Eastern & Traditional Medicine

Traditional Chinese Medicine (TCM)

MS is framed as disruption of qi and blood with internal wind, dampness, and phlegm obstructing channels, often alongside liver–kidney yin or spleen qi deficiency. Goals are to dispel wind/dampness, resolve phlegm, nourish liver–kidney, and restore flow to support strength, balance, and fatigue reduction.

Techniques

  • Acupuncture for spasticity, pain, paresthesia, and fatigue (commonly used points individualized; examples reported include DU20, GB20, LI4, ST36, SP6, BL23)
  • Electroacupuncture for spasticity in some clinics
  • Chinese herbal formulas tailored to pattern (e.g., Du Huo Ji Sheng Tang for wind‑damp; Bu Zhong Yi Qi Tang for qi deficiency; individualized prescriptions)
  • Moxibustion and cupping in selected cases
  • Qigong/Tai Chi for balance, fatigue, and mood
Licensed acupuncturist (L.Ac.) TCM physician/Chinese medicine practitioner Integrative medicine physician with TCM training
Evidence: Emerging Research

Ayurveda

MS is often interpreted as a vata‑predominant neurological disorder (vata vyadhi) with possible kapha involvement. Care aims to pacify vata, reduce ama (metabolic by‑products), nourish ojas (vitality), and support nervous system resilience.

Techniques

  • Dietary prescriptions favoring warm, unctuous, easily digested foods and regular routines
  • Abhyanga (oil massage), shirodhara, and other sneha therapies
  • Panchakarma detoxification protocols in specialized centers
  • Rasayana botanicals traditionally used for nervous system support (e.g., Withania somnifera [ashwagandha], Bacopa monnieri [brahmi], Centella asiatica [gotu kola]); formulas individualized by practitioner
  • Yoga and pranayama integrated as daily practice
Ayurvedic physician (BAMS) Ayurvedic practitioner/therapist Integrative medicine physician with Ayurvedic training
Evidence: Traditional Use

Kampo (Japanese Traditional Medicine)

Kampo adapts classical Chinese herbal theory with standardized formulas chosen by sho (pattern) such as qi/blood deficiency, cold, or dampness presentations. Goals include warming, moving blood, and strengthening constitution to ease fatigue and stiffness.

Techniques

  • Standardized formulas (e.g., keishibukuryogan for blood stasis, hochuekkito for qi deficiency) chosen by sho
  • Adjunct acupressure and moxibustion where available
  • Dietary and lifestyle guidance consistent with pattern
Kampo physician (Japan) Integrative MD/DO trained in Kampo
Evidence: Emerging Research

Yoga and Mindfulness (Mind–Body Medicine)

Mind–body practices aim to modulate stress reactivity, improve fatigue, mood, sleep, and quality of life, and support balance and mobility through gentle movement and breathwork.

Techniques

  • Hatha yoga with adapted asanas for mobility/spasticity
  • Pranayama (breath regulation) and relaxation practices
  • Mindfulness‑Based Stress Reduction (MBSR) and meditation programs
  • Group classes or home‑based, carefully modified routines
Certified yoga therapist/instructor with neurorehabilitation experience Clinical psychologist or clinician trained in MBSR/MBCT Rehabilitation therapist integrating mind–body approaches
Evidence: Moderate Evidence

Sources

  • A 2021–2022 systematic review of acupuncture for MS symptoms reported small, heterogeneous trials with possible benefits for pain, spasticity, and fatigue but overall low‑certainty evidence
  • Reviews of Chinese herbal medicine for MS describe traditional use and preliminary studies, with limited high‑quality RCT data and safety concerns for specific herbs (e.g., Tripterygium wilfordii)
  • Tai Chi/Qigong trials in MS suggest improvements in balance and fatigue with low to moderate‑quality evidence
  • Classical Ayurvedic texts describe vata vyadhi management emphasizing oleation, warming, and rasayana therapies
  • Modern evidence for Ayurveda specifically in MS consists mainly of case series and small uncontrolled studies; robust RCTs are lacking
  • Kampo research in MS is limited to small observational reports; formal RCTs specific to MS are scarce. Some formulas have broader evidence in fatigue or circulation, not MS‑specific
  • Systematic reviews and RCTs report improvements in fatigue, depression, and quality of life with yoga and mindfulness in MS, with low to moderate‑certainty evidence
  • Exercise therapy reviews support aerobic/resistance/yoga‑like movement for fatigue and function in MS

Integrative Perspective

An integrative plan typically anchors on evidence‑based DMTs and rehabilitation while using complementary modalities to target persistent symptoms and enhance well‑being. Practical combinations include: yoga or mindfulness alongside conventional exercise programs to reduce fatigue, anxiety, and sleep disturbance; a monitored trial of acupuncture for spasticity, neuropathic pain, or paresthesia; and nutritional optimization (e.g., correcting vitamin D deficiency under clinician supervision). Cannabis‑based products may help spasticity and pain for some patients where legal, though cognitive and psychiatric side effects, driving safety, and drug–drug interactions must be weighed. Research directly testing combined approaches is limited, but small studies suggest additive benefits in quality of life when mind–body practices are layered onto standard care. Risk management is central. Many DMTs affect infection risk and liver function; herbs with immunostimulatory or hepatotoxic potential (e.g., echinacea, kava, concentrated green tea extracts, certain TCM botanicals such as Tripterygium wilfordii) can pose added risk. St John’s wort can alter metabolism of multiple drugs; ginkgo may increase bleeding risk; licorice may exacerbate hypertension and potassium loss; cannabinoids can amplify sedation with CNS depressants. Product quality varies widely; some traditional preparations have been found to contain heavy metals or adulterants. Choosing third‑party tested supplements (USP, NSF, or equivalent), using single‑herb products when possible, and coordinating timing with infusions or lab monitoring help reduce harm. Licensed, well‑trained practitioners (acupuncturists, Ayurvedic/Kampo physicians, yoga therapists) who are comfortable collaborating with neurology teams can tailor approaches safely. Key guardrails clinicians and patients often prioritize include: full disclosure of all supplements and botanicals; verification of legal status and quality (especially for cannabis products); avoidance of unproven therapies in place of DMTs; extra caution around treatment transitions, relapses, infections, pregnancy, and procedures; and shared decisions about when to pause or sequence complementary care around high‑risk therapies (e.g., during HSCT). Consult your healthcare provider before making changes to your health regimen.

Sources

  1. AAN Evidence‑based Guideline: Complementary and Alternative Medicine in MS (2014) — cannabinoids may help spasticity/pain; insufficient evidence for many CAM; ginkgo not helpful for fatigue
  2. Cochrane Review (2020): Vitamin D for MS — uncertain effects on relapses/disability; correct deficiency for general health
  3. Cochrane Review (2012, updates): Omega‑3 fatty acids for MS — no clear benefit on relapses/disability
  4. ECTRIMS/EAN 2023 Pharmacological Treatment Guideline for MS — DMT recommendations by disease activity/risk
  5. 2017 McDonald Criteria for MS diagnosis (Thompson et al., Lancet Neurology)
  6. Systematic reviews of yoga/mindfulness in MS (2019–2022) — improvements in fatigue, mood, QoL; low‑to‑moderate certainty
  7. Systematic review of acupuncture for MS symptoms (2021/2022) — mixed results, low‑certainty evidence
  8. Trials/meta‑analyses of cannabis‑based medicines for MS spasticity and pain (AAN, Cochrane reviews up to ~2020) — modest benefit with adverse effects
  9. Reviews of Chinese herbal medicine and Kampo formulas in MS — limited RCTs; safety and quality concerns highlighted

Related Content

relationships

Multiple Sclerosis and Chronic Fatigue

Multiple sclerosis (MS) is a chronic, immune-mediated demyelinating disease of the central nervous system. Fatigue—often described as an overwhelming lack of physical and/or mental energy—is among its

comparisons

Alternatives for Multiple Sclerosis: East vs West

Alternatives for Multiple Sclerosis. “Alternatives for multiple sclerosis (MS)” can mean very different things depending on the goal. MS care typically aims to: prevent relapses, slow long‑term disability progression, manage day‑to‑day symptoms (fatigue, pain, spasticity, bladder and cognitive issues), and support quality of life. With

relationships

Multiple Sclerosis and Vitamin D

Multiple Sclerosis and Vitamin D. Multiple sclerosis (MS) is a chronic, immune-mediated disease of the central nervous system. Vitamin D, a secosteroid hormone produced in the skin by UVB light and obtained from diet, has long been linked to MS through geography, biology, and clinical research. Understanding their relationship matte

articles

Eastern vs Western Medicine: Key Differences in Philosophy, Diagnosis, Evidence, and When to Use Each

Eastern vs Western Medicine: Key Differences in Philosophy, Diagnosis, Evidence, and When to Use Each. If you’ve ever wondered how to choose between acupuncture and ibuprofen, or herbs and prescription drugs, you’re already asking the core question behind eastern vs western medicine. People seek clarity on which system works best, when to use each, and how to combine them safely. This guide compares

articles

Combining Eastern and Western Health Practices: An Evidence‑Based Guide to Integrative Care

Combining Eastern and Western Health Practices: An Evidence‑Based Guide to Integrative Care. If you’re curious about combining Eastern and Western health practices, you’re not alone. Many people want the diagnostic clarity of conventional medicine alongside the whole-person focus of Traditional Chinese Medicine (TCM), Ayurveda, yoga, mindfulness, and other mind–body tools. This guide walks

comparisons

ADHD and Alternative Medicine — East vs West: East vs West

ADHD and Alternative Medicine — East vs West. Attention-deficit/hyperactivity disorder (ADHD) is a common neurodevelopmental condition marked by persistent patterns of inattention, hyperactivity, and/or impulsivity that interfere with functioning at school, work, or home. Comparing Western medical and Eastern traditional approaches can help fam

Health Disclaimer

This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any supplement or medication regimen.